Could a drug you may already be taking help stop cancer?

December 1, 2019By CancerSmarterCancer Research, Cancer Treatments

Huff Post UK has reported on a drug commonly used to treat Parkinson’s disease that may also be used to stop cancer in some patients. Carbidopa, a drug used by many Parkinson’s patients has been shown to inhibit the growth of tumors in mice according to the Huff PostUK article and the Biochemical Journal. Professor Aideen Sullivan, University College, … Read More

Car-T therapy has my cancer on the run, says patient

September 12, 2019By CancerSmarterCancer Treatments

Researchers in the UK are using genetic engineering to reprogram leukemia patient’s own immune cells to fight cancer. The NHS was among the first to authorise the use of Car-T therapy, which is extremely expensive — with a list price of £280,000 ($355,544.00) per patient. For cancers of the blood, Car-T is considered cutting edge treatment. This video from … Read More

Exercise Should Be Prescribed To Cancer Patients

May 7, 2018By CancerSmarterCancer Treatments, Research

Clinical Oncology Society of Australia The Clinical Oncology Society of Australia researchers have published a paper finding that exercise should be prescribed to cancer patients. Exercise should be prescribed routinely along with the typical chemo, radiation treatments. The paper concludes that not doing so can be harmful to patients battling cancer. The “Exercise Pill” The … Read More

Tamoxifen promotes metastasis in some breast cancer cells

February 11, 2018By CancerSmarterCancer Research, Cancer Treatments, Carcinogens, Diagnostic Testing

Tamoxifen promotes metastasis in some breast cancer cells Tamoxifen works by blocking estrogen in the breast tissue by attaching to the estrogen receptors in breast cells. Recent studies show that tamoxifen promotes metastasis in some breast cancer cells. The drug has been used as a first-line endocrine treatment for  breast cancer for decades. Tamoxifen resistance In … Read More